Today’s Stock Market in 2-Minutes
May 22, 2026
-
-
Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries
May 22, 2026
-
PARKE BANCORP, INC. ANNOUNCES STOCK REPURCHASE PLAN
May 22, 2026
-
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
May 22, 2026
-
Top News
- Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases May 22, 2026
- Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II May 22, 2026
- BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting May 22, 2026
- BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT(TM) at ASCO 2026 May 22, 2026
Sequire Spotlight Presents: Gevo (GEVO) – Drop-In Jet Fuel From Renewables Poised for Scale
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Popular Reads
-
Biofrontera Inc.: A Dermatology Company Scaling with Momentum
April 8, 2026
-
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced the pricing of an underwritten, registered offering (the offering) of an aggregate of 3,358,602 shares of common stock at an offering price per share of common […]
May 22, 2026
-
Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries
BEIJING, May 22, 2026 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced a platform development milestone for Gausspeed, its generative AI […]
May 22, 2026
-
BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
TEL AVIV, Israel and OSLO, Norway, May 22, 2026 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company developing novel small molecule therapeutics, today announced that two abstracts featuring GLIX1 will be published at the American Society of Clinical Oncology […]
May 22, 2026
News
-
Today’s Stock Market in 2-Minutes
May 22, 2026
-
Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries
May 22, 2026
-
Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II
May 22, 2026
-
BayCom Corp Announces Cash Dividend
May 22, 2026
-
PARKE BANCORP, INC. ANNOUNCES STOCK REPURCHASE PLAN
May 22, 2026
-
Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases
May 22, 2026
-
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT(TM) at ASCO 2026
May 22, 2026
-
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
May 22, 2026